Concavit capsules

Country: United Kingdom

Bahasa: Inggeris

Sumber: MHRA (Medicines & Healthcare Products Regulatory Agency)

Bahan aktif:

Vitamin A; Ergocalciferol; Ascorbic acid; Thiamine nitrate; Riboflavin; Pyridoxine hydrochloride; Nicotinamide; Calcium pantothenate; Alpha tocopheryl acetate

Boleh didapati daripada:

Wallace Manufacturing Chemists Ltd

INN (Nama Antarabangsa):

Vitamin A; Ergocalciferol; Ascorbic acid; Thiamine nitrate; Riboflavin; Pyridoxine hydrochloride; Nicotinamide; Calcium pantothenate; Alpha tocopheryl acetate

Dos:

5000unit ; 500unit ; 40mg ; 2.5mg ; 2.5mg ; 1mg ; 20mg ; 5mg ; 2unit

Borang farmaseutikal:

Oral capsule

Laluan pentadbiran:

Oral

Kelas:

No Controlled Drug Status

Jenis preskripsi:

Never Valid To Prescribe As A VMP

Ringkasan produk:

BNF: 09100000; GTIN: 05034593044603 05034593043606

Risalah maklumat

Concavit Capsules
Concavit Capsules
Each Capsule contains: -
Vitamin A BP
5000.00 iu
Calciferol BP
500.00 iu
Ascorbic Acid BP
40.00 mg
Thiamine Mononitrate BP
2.50 mg
Riboflavine BP
2.50 mg
Pyridoxine Hydrochloride BP
1.00 mg
Nicotinamide BP
20.00 mg
Calcium Pantothenate BP
5.00 mg
dl-

-Tocopheryl Acetate BP
2.00 iu
In addition the capsules also contain: Soya Bean Oil, Fat mixture,
Soya Lecithin, Gelatin, Glycerin,
Sorbitol, Hydroxybenzoates (Ethyl and Propyl), Ponceau 4R (E124) and
water.
Concavit capsules are available in packs of 25 and 100.
Concavit is an oral vitamin supplement.
The product licence holder is Wallace Manufacturing Chemists Ltd.,
Wallace House, 51-53 Stert
Street, Abingdon, Oxfordshire OX14 3JF, United Kingdom and the
capsules are manufactured by
Catalent UK Swindon Encaps Limited, Frankland Road, Blagrove Estate,
Swindon, Wiltshire SN5
8YG, England.
Product Licence No: PL 00400/5009R
Concavit is intended as a multiple vitamin supplement in situations of
special dietary need. It is not
intended for the correction of specific vitamin deficiencies.
BEFORE YOU USE CONCAVIT
Do not use Concavit to treat vitamin deficiencies caused by inability
to absorb the vitamin(s) orally.
Do not use Concavit if:

You are hypersensitive to any of the ingredients

You have a history of high levels of Vitamins A or D

You have bone tumours

You have elevated blood calcium levels.

You have abnormal metabolic sensitivity to vitamin D
Do not take Vitamin A supplements if you are pregnant or likely to
become pregnant except on the
advice of your doctor or antenatal clinic.
PRECAUTIONS FOR THE USE OF CONCAVIT
Do not exceed the stated dose.
INTERACTIONS WITH OTHER MEDICINE
Concavit may react with other medicines you are taking. Concavit
contains a range of Vitamins and
each can affect and in turn be affected by other medicines you are
taking. Consult with your doctor or
pharmacist if you are taking other medicines.
The following medicines will alter the absorption of one or more
ingredients in Concav

Ciri produk

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Concavit Capsules
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each Capsule contains: -
Vitamin A BP
5000.00 iu
Calciferol BP
500.00 iu
Ascorbic Acid BP
40.00 mg
Thiamine Mononitrate BP
2.50 mg
Riboflavine BP
2.50 mg
Pyridoxine Hydrochloride BP
1.00 mg
Nicotinamide BP
20.00 mg
Calcium Pantothenate BP
5.00 mg
dl-
α
-Tocopheryl Acetate BP
2.00 iu
3.
PHARMACEUTICAL FORM
Soft Gelatine Capsules
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
As a supplement of multiple vitamins in situations of special dietary
need. Not
suitable for the correction of specific vitamin deficiencies.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Adults, The Elderly and Children - 1 capsule daily
4.3
CONTRAINDICATIONS
•
Oral administration in the treatment of deficiency state in
malabsorption
syndromes.
•
Hypersensitivity to any of the ingredients.
•
History of hypervitaminoses A or D.
•
Sarcoidosis
•
Hypercalcaemia
•
Abnormal metabolic sensitivity to Vitamin D.
•
Do not take Vitamin A supplements if you are pregnant or likely to
become pregnant except on the advice of a doctor or antenatal clinic.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
There are serious risks of developing hypercalcaemia when calcium
salts or
thiazides
are
co-administered.
Serum
calcium,
phosphate,
alkaline
phosphatase, liver function tests and magnesium should be monitored
when
indicated.
Absorption of Vitamin A is reduced in cystic fibrosis, hepatic
diseases,
pancreatic dysfunction and in patients with intestinal infections. The
use of
Vitamin A in renal diseases requires extreme caution.
4.5
INTERACTIONS WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
•
Contraceptive pills raise plasma levels of Vitamin A.
•
Agents such as bile acid resins, e.g. cholestyramine and colestipol
impair
the absorption
of fats including the Vitamins A and D.
•
As
both
Vitamin
D
and
thiazide
diuretics
increase
the
plasma
concentration of calcium,
co-administration of these agents may res